DDI of the Month Podcast
The very latest updates on Drug-Drug Interactions hot off the presses!
Discover the Latest Episode
Available now on Spotify and Apple Podcasts
Guest Speaker Episode 1 | Flucloxacillin
Ditte B. Iversen, PhD, MSc Pharm
University of Southern Denmark, Denmark
In the first exciting episode of this new podcast series, Dr. Iversen and Dr. Burger will dive into DDIs with flucloxacillin, and explore the results of Dr. Iversen's research trial.
Flucloxacillin is widely used to treat infections and is known to be an agonist of the nuclear receptor PXR. Combined with comedications, it may give an increased risk of drug-drug interactions and no guideline is available yet.
Dr. Iversen’s research group has studied the extent of induction of flucloxacillin of the CYP enzymes in healthy adults and 3D spheroid of primary human hepatocytes (PHHs). The research group performed a randomized, unblinded, two-period, cross-over, clinical pharmacokinetic (Basel) cocktail study with twelve healthy adults. During the podcast, the study will be discussed in detail.
Find out the interesting results of this study!
About the Podcast
How do you avoid adverse drug interactions in this rapidly evolving field of pharmacological therapies?
Presented by Global DDI Solutions in collaboration with Academic Medical Education, the DDI of the Month podcast brings you the latest updates on drug-drug interactions.
Each month, a new paper will be selected and the author invited to discuss their findings and explore how this can optimize DDI management and patient care going forward.
The podcast intended for everyone interested in DDI management or specific drugs, e.g. healthcare professionals, pharmacists, and researchers.
Go to the DDI Manager website to utilize the online resources designed to assist healthcare professionals in prescribing and enhancing overall quality of life for their patients.
You can access a DDI manager for a specific disease and search for the related drugs from there.